Drugs / HYNR-CS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02210624 | Mar 2013 → Dec 2018 | brain hypoxia - ischemia | Hyun Young Kim | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HYNR-CS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02210624 ↗ |
| Modality | Cell therapy | “autologous bone marrow-derived stem cells therapy” NCT02210624 ↗ |
| Route | Intrathecal | “Intrathecal injection” NCT02210624 ↗ |